SS-31 integrates into mitochondrial membranes and modulates surface charge, reducing calcium stress — revealing the biophysical mechanism behind its protective effects.
Surface charge modulationSS-31 binds mitochondrial membranes proportionally to negative charge and reduces calcium stress at the interface
What the researchers found
SS-31 partitions into the mitochondrial membrane interface and modulates surface electrostatics in a charge-dependent manner, with demonstrated reduction of calcium stress as a proof-of-concept protective mechanism.
Why it matters
Understanding exactly how SS-31 interacts with mitochondrial membranes enables rational design of improved variants — critical since elamipretide is already in clinical trials for mitochondrial diseases.
The numbers in context
Binding proportional to surface charge; no bilayer destabilization; altered lipid packing; reduced calcium stress in mitochondria
How the study worked
Biophysical and computational study using model lipid bilayers and mitochondrial membranes to characterize SS-31 binding, membrane effects, and calcium distribution.
Who was studied
Model lipid bilayers and isolated mitochondrial membranes
What this study cannot tell us
In-vitro study using model membranes; in-vivo membrane conditions are more complex; calcium modulation shown as proof of concept but not fully characterized in living cells.
How to read the evidence
Rigorous biophysical characterization with complementary computational and experimental approaches, but limited to model membranes and in-vitro mitochondria.
When this study was published
Published in 2020; elamipretide continues in clinical trials for Barth syndrome and other mitochondrial conditions.
The bigger picture
This mechanistic work bridges the gap between SS-31's observed clinical benefits and its molecular actions, providing a framework for designing next-generation mitochondria-targeted peptides.
Questions still open
- Can this electrostatic modulation mechanism be optimized to create more potent SS-31 variants?
- How does SS-31 membrane interaction change in diseased mitochondria with altered cardiolipin composition?
- Does the surface charge mechanism explain SS-31 efficacy across its diverse therapeutic applications?
Common questions
How does SS-31 (elamipretide) protect mitochondria?
What is elamipretide used for?
Read the original research
The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action.
The Journal of biological chemistry, 295(21), 7452-7469
Citation
Mitchell, Wayne; Ng, Emily A; Tamucci, Jeffrey D; Boyd, Kevin J; Sathappa, Murugappan; Coscia, Adrian; Pan, Meixia; Han, Xianlin; Eddy, Nicholas A; May, Eric R; Szeto, Hazel H; Alder, Nathan N. (2020). The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action.. The Journal of biological chemistry, 295(21), 7452-7469. https://doi.org/10.1074/jbc.RA119.012094